Cardio Diagnostics Holdings (CDIO) Operating Leases (2023 - 2025)
Cardio Diagnostics Holdings (CDIO) posted Operating Leases of $364383.0 for Q4 2025, down 39.78% sequentially from $605089.0 in Q1 2025, and down 14.43% YoY from $425829.0 in Q4 2024.
Cardio Diagnostics Holdings (CDIO) Operating Leases (2023 - 2025) Analysis & Trends
Cardio Diagnostics Holdings has reported Operating Leases for 3 years, with the latest figure at $364383.0 in Q4 2025.
- Quarterly Operating Leases fell 14.43% year-over-year to $364383.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $364383.0 (down 14.43% YoY) and the FY2025 annual result came in at $364383.0, down 14.43% from the prior year.
- Operating Leases retreated to $364383.0 in Q4 2025 per CDIO's latest filing, from $605089.0 in the prior quarter.
- Over five years, Operating Leases peaked at $898534.0 in Q3 2023 and troughed at $364383.0 in Q4 2025.
- A 3-year average of $658258.4 and a median of $681495.5 in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2024 and 2025: Operating Leases plunged 33.73% in 2024, then decreased 14.43% in 2025.
- Over 3 years, Operating Leases stood at $642523.0 in 2023, then slumped by 33.73% to $425829.0 in 2024, then dropped by 14.43% to $364383.0 in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $364383.0, $605089.0, and $425829.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Cardio Diagnostics Holdings | 6.03 Mn | 443,812.80 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 364,383.00 |
| Mar 31, 2025 | 605,089.00 |
| Dec 31, 2024 | 425,829.00 |
| Sep 30, 2024 | 720,468.00 |
| Jun 30, 2024 | 776,948.00 |
| Mar 31, 2024 | 832,293.00 |
| Dec 31, 2023 | 642,523.00 |
| Sep 30, 2023 | 898,534.00 |